Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti–PD-L1 immunotherapy
0301 basic medicine
Receptors, CXCR4
03 medical and health sciences
Lung Neoplasms
Tumor Microenvironment
Humans
Immunotherapy
Research Articles
B7-H1 Antigen
Signal Transduction
3. Good health
DOI:
10.1126/sciadv.aaz9240
Publication Date:
2020-05-15T23:59:07Z
AUTHORS (6)
ABSTRACT
CXCR4 antagonistic nanocomplex regulates the immune process to enhance anti–PD-L1 immunotherapy.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (47)
CITATIONS (132)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....